AT-GC BioPharm

AT-GC BioPharm is developing a standardized manufacturing platform that uses its proprietary `Electronic Eye` technology that assures product quality in all stages of the drug development chain.
Our key to success is to integrate the process development with manufacturing and efficient drug delivery systems for gene and protein based therapeutics with consistent quality control and assurance.

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Manufacturing
- Regulatory Affairs & Legal Services
- Research & Development

Product / Technology type(s) covered:

- Bio
- Cosmoceuticals
- Diagnostics
- Drug delivery
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Preventive
- Proteins
- Technology

Therapeutic targets:

- AIDS
- Cancer
- Epidemiology
- Genetics
- Infectious Diseases
- Oncology
- Pain

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Asia , Europe , Near/Middle East

c. Countries active: US, India

Corporate data:

Number of Employees: 12

Turnover:

Amount:	Year:	Currency:
-	2002	US Dollar

Year founded: 2003

Partners / Alliances: 1. Avanti Therapeutics
2. Nucleonics, Inc.
3. Synergy Pharmaceuticals